Linked Data API

Show Search Form

Search Results

1683320
registered interest false more like this
date less than 2024-01-18more like thismore than 2024-01-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Waiting Lists more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps she is taking to reduce waiting times for treatments for (a) breast, (b) ovarian and (c) prostate cancer. more like this
tabling member constituency Bolton South East remove filter
tabling member printed
Yasmin Qureshi more like this
uin 10442 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-01-24more like thismore than 2024-01-24
answer text <p>Reducing waiting times for treatments of all types of cancer is a priority for the Government, as is increasing early cancer diagnosis as this is a key contributor to reducing cancer health inequalities. We are expanding capacity through our community diagnostic centres (CDCs) supported by £2.3 billion of capital funding with 150 CDCs currently operational and having delivered over six million additional tests, checks and scans including vital cancer checks since January 2021.</p><p>The planned Major Conditions Strategy will look at the early diagnosis and treatment of cancer and will consider a wide range of interventions and enablers to improve outcomes and experience for a range of cancer patients, including those less survivable cancers.</p><p>NHS England has commissioned six cancer clinical audits which will provide timely evidence for cancer service providers of where patterns of care in England may vary, increase the consistency of access to treatments and help stimulate improvements in cancer treatments and outcomes for patients, including ovarian cancer, pancreatic cancer, non-Hodgkin lymphoma, kidney cancer and primary and metastatic breast cancer. The Royal College of Surgeons began work on this audit in October 2022, and the first outcomes expected in September 2024.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
remove filter
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
3924
label Biography information for Yasmin Qureshi more like this